CClinicalTrials.gg
RecruitingNCT06092320Updated Jul 5, 2024

Does Teaching Before or After Simulation Improve Learning?

An interventional study of Simulation on Pediatric Status Epilepticus and Didactic Lecture on Pediatric Status Epilepticus in Medical Education and Simulation, sponsored by University of British Columbia. Recruiting at 1 site in Canada. Per ClinicalTrials.gov, last updated 2024-07-05.

Sponsored by University of British Columbia · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Started Sep 2023; still recruiting 3 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Sex
All
01

Study summary

The goal of the randomized educational intervention study is to test whether simulation preceding didactic teaching leads to improved knowledge and performance retention compared to a didactic lecture proceeding simulation for medical students

Participants will be randomized to one of two different groups with reverse orders for simulation and lectures.

Researchers will compare each group to see which way is better for learning.

02

Conditions studied

  • Medical Education
  • Simulation

Keywords

  • Medical Education
  • Simulation
  • Pediatrics
03

In context

Lead sponsor

University of British Columbia is the lead sponsor of 1,309 studies on the registry; 253 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Second year medical student at the University of British Columbia

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Simulation - Didactic Lecture Group

    This group will start with a Simulation and debrief followed by a didactic lecture afterwards. They will then complete a simulation 2 months later.

    Other: Simulation on Pediatric Status Epilepticus · Other: Didactic Lecture on Pediatric Status Epilepticus

  • Experimental
    Didactic Lecture - Simulation Group

    This group will start with a didactic lecture and then complete a simulation and debrief. They will then complete a simulation 2 months later.

    Other: Simulation on Pediatric Status Epilepticus · Other: Didactic Lecture on Pediatric Status Epilepticus

Interventions

  • OtherSimulation on Pediatric Status Epilepticus

    The participants will complete a simulation session and debrief lead by a pediatric emergency medicine physician on status epilepticus.

  • OtherDidactic Lecture on Pediatric Status Epilepticus

    The participants will complete a lecture on pediatric status epilepticus

06

What researchers measure

Primary outcomes

  1. Change from baseline in resuscitation performance retention score 2 months post-initial training assessed using global simulation performance score

    The scoring sheet used will be the Global Simulation performance score a one to seven scale that assess over medical expertise performance in the simulation with higher values representing increased competence.

    Time frame: From initial simulation until repeat simulation 2 months later

Secondary outcomes

  1. Change in knowledge assessment score at 2 months post-initial training assessed using an MCQ

    The knowledge test is a 15 questions multiple choice exam scored from 0 to 15 with higher numbers representing a higher score.

    Time frame: From initial knowledge test until repeat testing 2 months later

  2. Learner satisfaction measured by Likert scale items after each simulation debrief

    The Likert scale will be a one to five scale with higher scores representing increased satisfaction

    Time frame: Single time metric completed five minutes after initial simulation session

  3. Time to resuscitation metrics

    The following "time to" metrics will be measured from simulation start until completion of each activity within that simulation: glucose check, IV access, first-line anti-epileptic administration, second-line anti-epileptic administration, chemistry panel

    Time frame: The time for each metric will be measured once during the second evaluatory simulation 2 months after the initial simulation and participant enrolment.

07

Study locations

1 of 1 sites recruiting
  • BC Children's Hospital
    Vancouver, British Columbia V6H 3N1, Canada
    Recruiting
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Aug 16, 2023
  • Informed consent form · Aug 16, 2023

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06092320
Lead sponsor
University of British Columbia
Responsible party
Melissa Chan (Principle Investigator, University of British Columbia) — Principal investigator
First posted
Oct 23, 2023
Start date
Sep 20, 2023
Primary completion
Jun 2025 (estimated)
Completion
Jun 2025 (estimated)
Last update
Jul 5, 2024

Study contacts

John Ramsay, MD
Contact
john.ramsay1@phsa.ca
(604) 875-2345
Melissa Chan, MD
principal investigator · Provincial Health Services Authority

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion